Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FQWJ1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,374
Award facts
- Contract value 100% obligated
- $27,374.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,374 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, issued on January 5, 2026, with an ultimate completion date of January 27, 2026, was awarded without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) through the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated contract SPE2DR, which carries a ceiling value of $499,999,999 and extends through December 31, 2036.
DMS Pharmaceutical Group has been registered in the System for Award Management since 2001 and serves as a critical pharmaceutical supplier to Department of Defense healthcare facilities. The company's established performance on the PPV-G GEN V contract, which represents one component of a $30.3 billion acquisition strategy, enables the DLA to issue delivery orders for diverse pharmaceutical products including branded and generic medications, biologics, vaccines, and medical consumables. The Mirena system delivery under this order supports recurring medical supply needs of military healthcare facilities, demonstrating the contractor's role in sustaining pharmaceutical inventory for DoD operations.
Quick answers
Who was awarded contract SPE2DR26FQWJ1?
SPE2DR26FQWJ1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FQWJ1 worth?
The government has obligated $27,374 on SPE2DR26FQWJ1.
Is contract SPE2DR26FQWJ1 an order under another contract?
Yes. SPE2DR26FQWJ1 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWJ1 competed?
The extent of competition for SPE2DR26FQWJ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award